Oncology Companion Diagnostics Market Size 2022-2028- Rising Prevalence Of Cancer Across The Globe Is A Key Factor Driving Market Growth

Growing burden of cancer, rising demand for personalized medicine, and increasing collaborations to co-develop drug and diagnostic technologies are key factors driving market growth  

The global oncology companion diagnostics market size is expected to reach USD 6.60 Billion by 2028 and register a CAGR of 13% over the forecast period, according to the latest report by Reports and Data. Increasing incidence of cancer across the globe, rising application of companion diagnostic in cancer management, and increasing advancements in personalized medicine are key factors expected to drive market revenue growth over the forecast period. In addition, increasing importance of oncology companion diagnostics in next-generation omics and growing use of CDx to ensure safety and efficacy of drugs and treatment are also expected to drive revenue growth of the market going ahead.

Companion diagnostics is a crucial part of pharmacogenomics which leverages genetic makeup of an individual to predict response to a therapeutic approach or to design a personalized therapy for the patient. Companion diagnostics has been widely applied in personalized medicine to assist in shaping up the development process for a particular drug. The FDA regulates a companion diagnostics based on how it will be used in delivering therapeutics and care in medicine. Companion diagnostics are also useful in determining the appropriate and effective use of a therapeutic. It also plays a pivotal role in screening patients who will benefit from the drug and who should not be treated with the specific drug. In oncology, companion diagnostic plays a crucial part in narrowing the population for a treatment to ensure better outcomes and decrease risk of treatment. In addition, advent of high-throughput and sensitive approaches such as Next-Generation Sequencing (NGS) and quantitative histopathology, among others have resulted in rapid development of platforms for CDx. This is also expected to contribute to market growth going ahead.

Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/4092

Increasing advancements in companion diagnostics has resulted in rising number of collaboration and partnerships in biotechnology and pharmaceutical companies to expand product portfolio and this is expected to fuel market growth. However, complicated clinical diagnostic scenario, limitations of clinical application of CDx, and low awareness in developing and underdeveloped countries are expected to restrain market growth to a certain extent over the forecast period.

Some Key Highlights From the Report:

  • Product segment is expected to account for largest revenue share in the global market owing to increasing application of companion diagnostics in treatment and management of cancer, development of improved consumables and reagents, and advancements in diagnostic technologies.
  • Immunohistochemistry segment is expected to register considerable revenue growth over the forecast period, attributable to availability of a broad range of IHC-based diagnostic solutions for cancer, growing product approvals, and increasing progress of drug discovery and research.
  • Non-small cell lung cancer accounted for largest revenue share in 2020 and is expected to register significant revenue growth owing to increasing prevalence of non-small cell lung cancer, increasing research for companion diagnostics, and growing need for personalized medicine.
  • Hospitals segment is expected to register robust revenue CAGR over the forecast period owing to increasing availability of advanced healthcare infrastructure, development of accurate and sensitive cancer screening and diagnostic assays, and favorable reimbursement scenario.
  • North America accounted for a revenue share of 39.7% in the global market in 2020, attributable to rising research and development activities, increasing awareness about oncology companion diagnostics, and progress in precision medicine. In addition, rising prevalence of cancer, increasing number of product approvals, and robust presence of key market players in the region.
  • Major companies in the global market include Agilent Technologies, Inc., Illumina, Inc., QIAGEN N.V., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., ARUP Laboratories, Abbott Laboratories, Myriad Genetics, Inc., bioMérieux SA, and Invivoscribe, Inc.
  • In April 2021, Illumina, Inc. and Kartos Therapeutics joined forces to co-develop an NGS-based TP53 companion diagnostic based on TruSight Oncology 500, which is Illumina’s comprehensive genomic profiling assay. The collaboration will primarily focus on co-developing CDx for blood cancers for KRT-232, which is a potent and highly selective oral MDM2 inhibitor developed by Kartos that activates p53 to cause tumor cell death in TP52 wild-type cancer.

Get In detailed Research Study @ https://www.reportsanddata.com/report-detail/oncology-companion-diagnostics-market

For the purpose of this report, Reports and Data has segmented the oncology companion diagnostics market based on product & service, technology, disease type, end-use, and region:  

Product & Service Outlook (Revenue, USD Billion; 2018-2028)

  • Products
    • Consumables
    • Instrument
    • Software
  • Services

Technology Outlook (Revenue, USD Billion; 2018-2028)

  • Polymerase Chain Reaction (PCR)
  • Next-Generation Sequencing (NGS)
  • Immunohistochemistry (IHC)
  • In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
  • Others

Disease Type Outlook (Revenue, USD Billion; 2018-2028)

  • Breast Cancer
  • Non-Small Cell Lung Cancer
  • Colorectal Cancer
  • Leukemia
  • Melanoma
  • Prostate Cancer
  • Others

End-use Outlook (Revenue, USD Billion; 2018-2028)

  • Hospitals
  • Pathology/Diagnostic Laboratory
  • Academic Medical Centers

Download Summary @ https://www.reportsanddata.com/download-summary-form/4092

Regional Outlook (Revenue, USD Billion; 2018-2028)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • U.A.E.
    • South Africa
    • Rest of MEA

Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/4092

Some points on how the report benefits stakeholders:

  • The reports include historical (2018–2020) and forecast (2021–2028) data points, revenues, and CAGR in table, figure, and chart formats, with detailed and qualitative, supporting written information for each.
  • Revenue break-up is provided for each segment in these formats for global, regional, and for each country in the respective region for each year between 2018 and 2028.
  • The report contains insights regarding growth drivers, restraints, opportunities, trends, company profiles, strategic developments, expansion details, product launches, and various other aspects related to the market.
  • The report contains data and information on customers, competitors, vendors/distributors, and other players and in the global marketplace.
  • Market research analysis is vital for all crucial business strategies and can aid in numerous ways and to provide a clearer understanding about strategies being deployed by competitors, product launches, competitive analysis, technological advancements and various other factors that enhance sales of a firm or perhaps provide insights to focus on merger and acquisition as a strategy or enter into strategic agreements or joint ventures etc.
  • The report contains company profiles of the top companies operating in the market along with their respective revenue and operating segments, geographical reach, market footprint, headquarters, growth rates, recent developments, product /services, expansion strategies, investments in expansion, and more.

Explore Latest Trending Research Reports By Reports and Data's

Ostomy Care Bag Market , By Product Type (Seals/Barrier Rings, Pouch Cover, Pouch Closures, Stoma Caps/Hat and Others), By Application (Home Care Settings, Hospitals and Others) and By Region Forecast to 2028

Medical Device Cleaning Market , By Process (Disinfection, Automatic Cleaning, Manual Cleaning, Presoaking/Precleaning), By Application, By End-Use, and By Region Forecast to 2028

Tinea Pedis Treatment Market , By Disease Type (Interdigital Tinea Pedis, Plantar Tinea Pedis, Vesicular Tinea Pedis), By Route of Administration (Oral and Topical [Gel, Creams, Spray, Lotions, and Powders]), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and E-Commerce), and By Region Forecast to 2028

Otitis Drug Market , By Disease Type (Acute Otitis Media, Otitis Media with Effusion, Chronic Otitis Media with Effusion), By Drug Types (Antibiotics, Non-steroidal Anti-inflammatory, Analgesic, Anaesthetic, Others), By End-User Type (Hospitals, Homecare, Specialty Clinics, Others), By Treatment Type (Medication and Surgery), and By Region Forecast to 2028.

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs

Read Latest Press Release @ https://www.reportsanddata.com/press-release/global-oncology-companion-diagnostics-market


Back to news